HTG Molecular EdgeSeq Pan B-Cell Lymphoma Panel

HTG Molecular Diagnostics has pre-launched its HTG EdgeSeq Pan B-Cell Lymphoma Panel, which the firm expects to offer as a kit or as a service for research use only use starting in July. The panel is designed to provide molecular characterization of aggressive lymphomas by allowing researchers to measure the expression of genes linked to the aggressive lymphoma transcriptome. The panel is an extension of HTG's DLBCL assay.